Capital Guardian Trust’s Celgene Corp CELG Stock Holding History

Capital Guardian Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-570	Closed	-$51K	–	514
2018 Q3	$51K	Buy	+570	New	+$50.4K	﹤0.01%	342
2017 Q2	–	Sell	-310	Closed	-$39K	–	652
2017 Q1	$39K	Sell	310 -3,547	-92%	-$424K	﹤0.01%	445
2016 Q4	$446K	Buy	3,857 +841	+28%	+$93.7K	﹤0.01%	285
2016 Q3	$315K	Buy	3,016 +1,191	+65%	+$129K	﹤0.01%	296
2016 Q2	$180K	Buy	1,825 +1,285	+238%	+$133K	﹤0.01%	330
2016 Q1	$54K	Buy	540 +95	+21%	+$9.78K	﹤0.01%	429
2015 Q4	$53K	Hold	445	–	–	﹤0.01%	447
2015 Q3	$48K	Hold	445	–	–	﹤0.01%	445
2015 Q2	$52K	Hold	445	–	–	﹤0.01%	442
2015 Q1	$51K	Buy	445 +135	+44%	+$16.1K	﹤0.01%	450
2014 Q4	$35K	Hold	310	–	–	﹤0.01%	429
2014 Q3	$29K	Hold	310	–	–	﹤0.01%	446
2014 Q2	$27K	Buy	310 +70	+29%	+$5.32K	﹤0.01%	426
2014 Q1	$17K	Sell	240 -4,200	-95%	-$333K	﹤0.01%	430
2013 Q4	$375K	Buy	4,440 +4,200	+1,750%	+$332K	﹤0.01%	262
2013 Q3	$19K	Hold	240	–	–	﹤0.01%	414
2013 Q2	$14K	Buy	+240	New	+$14.4K	﹤0.01%	422

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Guardian Trust's CELG Position: Q4 2018 in Review

Capital Guardian Trust sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 570 shares — an estimated $51K sold.

Capital Guardian Trust first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $446K in Q4 2016. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Capital Guardian Trust reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Capital Guardian Trust sold 570 Celgene Corp shares in Q4 2018, an estimated $51K.
Capital Guardian Trust first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
Capital Guardian Trust's Celgene Corp position peaked at $446K in Q4 2016.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.